Milk-producing protein, ELF5 Linked To Aggressive Breast Cancer

Australian scientists have shown how a ‘transcription factor’ causes breast cancer to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond to anti-oestrogen therapies such as Tamoxifen and aromatase inhibitors
http://www.garvan.org.au/news-events/news/the-factor-that-could-determine-future-breast-cancer-treatment.html (Click link to story)